MKI67 and neoplasm: The cisplatin-sensitive PDX tumours (models TC1 and TC5) showed a decrease in Ki-67 positive cells with increasing cisplatin concentrations, while no change in Ki-67 positivity was observed for the cisplatin-resistant model TC4.